Enanta Pharmaceuticals
Earnings Date & Report
Last updated:
Enanta Pharmaceuticals’s last earnings date was on 5 Feb 2024.
Enanta Pharmaceuticals stock Earnings report, Estimates & History
| 2019-08-06 | -0.00634 | 0.33 |
|---|---|---|
| 2019-11-21 | 0.514 | 0.44 |
| 2020-02-06 | 0.526 | 0.65 |
| 2020-05-06 | -0.10086 | -0.3 |
| 2020-08-04 | -0.59654 | -0.71 |
| 2020-11-23 | -2.23365 | -1.46 |
| 2021-02-08 | -0.22718 | -0.41 |
| 2021-05-06 | -1.2099 | -1.09 |
| 2021-08-05 | -1.10741 | -1.19 |
| 2021-11-22 | -1.2178 | -1.22 |
| 2022-02-08 | -2.02582 | -1.48 |
| 2022-05-09 | -1.86374 | -1.63 |
| 2022-08-08 | -1.68881 | -1.53 |
| 2022-11-21 | -1.19266 | -1.27 |
| 2023-02-07 | -1.21138 | -1.39 |
| 2023-05-08 | -1.98 | -1.63 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Enanta Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 5 Feb 2024 | N/A | N/A | N/A | N/A | N/A | |
| 20 Nov 2023 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 7 Aug 2023 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 8 May 2023 | Beat | -$1.98 | -$1.63 | 19.18M | N/A | Earnings Call Transcript |
| 7 Feb 2023 | Missed | -$1.21 | -$1.39 | N/A | 23.58M | Earnings Call Transcript |
| 31 Dec 2022 | N/A | N/A | -$1.39 | N/A | 23.58M | |
| 21 Nov 2022 | Missed | -$1.19 | -$1.27 | N/A | 20.31M | Earnings Call Transcript |
| 8 Aug 2022 | Beat | -$1.69 | -$1.53 | N/A | 19.47M | Earnings Call Transcript |
| 9 May 2022 | Beat | -$1.86 | -$1.63 | 16.09M | 18.71M | Earnings Call Transcript |
| 8 Feb 2022 | Beat | -$2.03 | -$1.48 | 27.39M | 27.64M | Earnings Call Transcript |
| 22 Nov 2021 | Missed | -$1.22 | -$1.22 | 27.39M | 23.57M | |
| 5 Aug 2021 | Missed | -$1.11 | -$1.19 | 21.86M | 21.62M | |
| 6 May 2021 | Beat | -$1.21 | -$1.09 | 17.87M | 20.13M | |
| 8 Feb 2021 | Missed | -$0.23 | -$0.41 | 41.30M | 31.74M | Earnings Call Transcript |
| 23 Nov 2020 | Beat | -$2.23 | -$1.46 | 12.03M | 23.63M | Earnings Call Transcript |
| 4 Aug 2020 | Missed | -$0.6 | -$0.71 | 22.06M | 18.65M | Earnings Call Transcript |
| 6 May 2020 | Missed | -$0.1 | -$0.3 | 81.93M | 27.61M | Earnings Call Transcript |
| 6 Feb 2020 | Beat | $0.53 | $0.65 | 44.48M | 52.57M | Earnings Call Transcript |
| 21 Nov 2019 | Missed | $0.51 | $0.44 | 61.80M | 51.31M | Earnings Call Transcript |
| 6 Aug 2019 | Beat | -$0.01 | $0.33 | 34.74M | 44.36M | Earnings Call Transcript |
Enanta Pharmaceuticals Earnings report FAQs
When is Enanta Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Enanta Pharmaceuticals's earnings date was on 7 Feb 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.